Cancer Nanotechnology - Most accessed articles

Breast cancer is the most common cause of cancer-related deaths among women globally and the most deadly illness for them. New advances in nanotechnology have led to the development of strategies...

https://cancer-nano.biomedcentral.com/articles/10.1186/s12645-024-00261-7

Nanocarrier delivery of small interfering RNAs (siRNAs) to silence cancer-associated genes is a promising method for cancer treatment. Here, we explored the role and mechanisms of PLAG NPs-delive...

https://cancer-nano.biomedcentral.com/articles/10.1186/s12645-024-00259-1

Colorectal cancer (CRC) ranks as the third most common cancer globally and the second leading cause of cancer-related mortality. Traditional chemotherapy, while effective, often results in signif...

https://cancer-nano.biomedcentral.com/articles/10.1186/s12645-024-00258-2

Effective drug delivery of nanomedicines to targeted sites remains challenging. Given that hypobaric hypoxia and hyperbaric oxygen exposure can significantly change pharmacokinetics of drugs, it ...

https://cancer-nano.biomedcentral.com/articles/10.1186/s12645-024-00257-3

The addition of the cyclin dependent kinase inhibitor (CDKi) dinaciclib to Poly-(ADP-ribose) polymerase inhibitor (PARPi) therapy is a strategy to overcome resistance to PARPi in tumors that exhi...

https://cancer-nano.biomedcentral.com/articles/10.1186/s12645-023-00240-4